We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BC:MILBrunello Cucinelli S.p.A. Analysis

Data as of 2026-03-14 - not real-time

€70.34

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading below its 20‑day, 50‑day and 200‑day moving averages, with a bearish MACD crossover and an RSI well into oversold territory, suggesting short‑term pressure but a potential bottom near the identified support level.
Fundamental backdrop: Valuation metrics are stretched – a trailing P/E above thirty‑five and a price‑to‑book near nine contrast sharply with a discounted cash‑flow estimate that is an order of magnitude lower, indicating the market is pricing in strong growth expectations. Financial health is mixed: while margins remain healthy and cash flow covers the dividend (payout under fifty percent), the balance sheet is levered with a debt‑to‑equity ratio exceeding two hundred percent, adding credit risk.
Risk & sentiment: Volatility is elevated, yet beta is modest, reflecting limited systematic risk but heightened company‑specific swings. The Fear & Greed index leans toward greed, hinting at bullish sentiment despite the bearish technical signals.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Oversold RSI and proximity to support suggest a tactical entry point
  • Increasing volume indicates growing market participation
  • Dividend yield provides modest income while price stabilises

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Valuation remains far above intrinsic estimates
  • High leverage could constrain earnings growth
  • Brand strength and margin profile support price stability

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Persistent overvaluation relative to DCF fair value
  • Elevated debt‑to‑equity raises solvency concerns over time
  • Luxury sector cyclicality may pressure earnings in a slowing economy

Key Metrics & Analysis

Financial Health

Revenue Growth10.00%
Profit Margin9.59%
P/E Ratio35.5
ROE26.52%
ROA7.85%
Debt/Equity210.65
P/B Ratio8.8
Op. Cash Flow€242.6M
Free Cash Flow€66.8M

Technical Analysis

TrendBearish
RSI27.5
Support€69.02
Resistance€88.76
MA 20€79.65
MA 50€83.71
MA 200€93.76
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair Value€5.91
Target Price€105.63
Upside/Downside50.16%
GradeOvervalued
TypeGrowth
Dividend Yield1.48%

Risk Assessment

Beta0.43
Volatility36.30%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.